<DOC>
	<DOCNO>NCT02078570</DOCNO>
	<brief_summary>The major purpose study evaluate laboratory developed test measure multiple breast cancer-specific biomarker proteins multiple antibody blood sample . The biomarker antibody result along personal medical profile evaluate determine risk presence malignancy breast compare breast evaluation assessment conduct physician .</brief_summary>
	<brief_title>Breast Cancer Biomarker Sample Collection dtectDx v2 Assay Proof Concept Protocol</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Adult woman 25 year age 75 year age Breast evaluation result ACR BIRADSÂ® Category 3 4 imaging physician clinical radiological evaluation Study visit blood collection within 4 week ( 28 day ) ACR BIRADS assessment Patient agree additional health data gather 6 month post assessment diagnostic followup Samples collect IRB approval Informed Consent Testing perform IRB approval waiver ( applicable ) Previous approve procedure enroll patient : breast augmentation &amp; cyst aspiration Adults 76 year age old 25 year age Final breast evaluation result ACR BIRADS Category 3 4 Subjects breast biopsy perform 6 month prior study visit Samples collect IRB approval Informed Consent Testing perform IRB approval waiver ( applicable ) Prior breast cancer diagnosis .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>